Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5500
Dr. Yim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2020 - 2025
University of California San Diego School of MedicineClass of 2020
Certifications & Licensure
MA State Medical License 2020 - 2025
Publications & Presentations
PubMed
- Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive N...Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard
European Urology Oncology. 2025-04-01 - Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies.Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Jeffrey Howard
European Urology Focus. 2025-02-07 - 4 citationsLong-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard
BJU International. 2025-02-01
Press Mentions
Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG RelapseDecember 2nd, 2022- Ultrasound and Robotic Surgery Advances: What Premeds Should KnowOctober 26th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
